Sixth Wave & York University Sign Amendment Halifax, Nova Scotia--(Newsfile Corp. - August 11, 2021) - Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave" or the "Company") is pleased to announce a signed amendment to the research agreement and grant sponsored by the Natural Sciences and Engineering Research Council of Canada ("NSERC") titled: Point-of-need Microfluidic Biosensor for Detecting Airborne Viruses using Molecularly Imprinted Polymers: Towards COVID-19 Virus Monitoring (the "NSERC Project"). The goal of the grant is to develop a portable, low-cost technology for rapid on-site air sampling and detection of aerosol and droplet-encapsulated viruses indoors and outdoors. The project is a collaboration between the Company and its partners, York University ("York") and the Centre Technologique des Residus Industriels ("CTRI"). The project had a start date of August 1, 2020. A copy of the proposal submitted to NSERC can be found here: https://sixthwave.com/NSERC2020.pdf.
Work to date has focused on designing a prototype(s) of the Company's AMIP technology to detect pathogens in airborne, water, and wastewater environments. The collaboration is part of Sixth Wave's multi-pronged R&D approach to revolutionize virus detection by being able to test individual patients as well as monitoring entire populations through proactive measures such as pathogen detection in a variety (buildings, ships, aircraft, etc.) of air handling systems (HVAC) and municipal wastewater treatment facilities.
The collaboration with York and CTRI has yielded new configurations and potential applications for the AMIP technology. Research conducted at York has demonstrated several of the previously disclosed potential capabilities of AMIP technology. Specifically, the integration of the technology into a variety of sensor arrays and detection mechanisms including electrochemical and fluorescent-based sensors. The work has also demonstrated the ability to detect a variety of pathogens, including viruses and bacteria. Although seemingly of similar origin, viruses and bacteria have drastically different technical challenges such as the different sizes and length scales of viruses vs. bacteria. The ability to develop the platform for different pathogens is a major milestone for SIXW. The imprinting and selective detection of multiple viruses and bacteria validate the claims of platform flexibility.
Microfluid devices or lab-on-a-chip devices are promising platforms to achieve rapid and sensitive immunological detection of pathogenic microorganisms such as bacteria and viruses. Inside these sub-microliter reactors, sample and reagent consumption can be significantly reduced, and the reaction time for target immobilization and identification can be shortened from hours to minutes or less.
"The signed amendment to the research agreement provides the Company a significant opportunity regarding various pathways to commercialization of our unique Accelerated Molecular Imprinted Polymers ("AMIPs™") technology," states Sherman McGill, Executive Vice-President and Chief Development Officer for Sixth Wave. Further, "We greatly value our collaborative relationship with York University and their confidence in Sixth Wave as evidenced by the amendment."
The Company's AMIPs technology allows for novel product configuration not possible with traditional testing techniques. As a result, AMIPs has greater stability and significantly less susceptibility to environmental variables such as heat, light, and other factors which may impact traditional testing methods.
Sixth Wave is using its expertise in MIP technology to bring innovative products to market and address the insufficiencies of current technologies exposed by the COVID-19 global pandemic.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.